Intelligent Bio Solutions Inc. (NASDAQ: INBS) recently showcased its innovative portable drug testing system at the RISE25 conference, marking a significant step in its U.S. expansion efforts. The company's Intelligent Fingerprint Drug Screening System utilizes fingerprint sweat to detect substances such as cannabis, cocaine, methamphetamine, and opiates, delivering results in less than ten minutes. This technology promises to enhance decision-making in treatment and justice settings by providing rapid, on-site drug screening.
The system's non-invasive nature and quick turnaround time represent a leap forward in drug testing methodologies, offering a less intrusive alternative to traditional blood or urine tests. With over 450 active accounts across 24 countries, INBS is targeting key sectors including healthcare, criminal justice, and workplace safety. The company's partnership with SMARTOX, a U.S. distributor, aims to broaden its reach within the criminal justice and addiction recovery communities.
Currently operating in a Forensic Use Only capacity in the U.S., INBS is pursuing FDA approval to expand its market presence. The demonstration at RISE25, attended by over 7,000 professionals from addiction treatment, mental health, and criminal justice fields, underscores the growing interest in rapid, non-invasive drug screening solutions. This development is poised to have a significant impact on how drug testing is conducted across various industries, offering a faster, more efficient, and less invasive option.
